Cell-based delivery of dATP via gap junctions enhances cardiac contractility.
Cell-based delivery of dATP via gap junctions enhances cardiac contractility.
复制标题
通过间隙连接进行基于细胞的 dATP 传递可增强心肌收缩力。
DOI:
10.1016/j.yjmcc.2014.04.010
复制
发表时间:
2014-07
影响因子:
5
通讯作者:
Regnier, Michael
中科院分区:
文献类型:
--
作者:
Lundy, Scott D.;Murphy, Sean A.;Dupras, Sarah K.;Dai, Jin;Murry, Charles E.;Laflamme, Michael A.;Regnier, Michael
关键词:
The transplantation of human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) is a promising strategy to treat myocardial infarction and reverse heart failure, but to date the contractile benefit in most studies remains modest. We have previously shown that the nucleotide 2-deoxyadenosine triphosphate (dATP) can substitute for ATP as the energy substrate for cardiac myosin, and increasing cellular dATP content by globally overexpressing ribonucleotide reductase (R1R2) can dramatically enhance cardiac contractility. Because dATP is a small molecule, we hypothesized that it would diffuse readily between cells via gap junctions and enhance the contractility of neighboring coupled wild type cells. To test this hypothesis, we performed studies with the goals of (1) validating gap junction-mediated dATP transfer in vitro and (2) investigating the use of R1R2-overexpressing hPSC-CMs in vivo as a novel strategy to increase cardiac function. We first performed intracellular dye transfer studies using dATP conjugated to fluorescein and demonstrated rapid gap junction-mediated transfer between cardiomyocytes. We then cocultured wild type cardiomyocytes with either cardiomyocytes or fibroblasts overexpressing R1R2 and saw more than a twofold increase in the extent and rate of contraction of wild type cardiomyocytes. Finally, we transplanted hPSC-CMs overexpressing R1R2 into healthy uninjured rat hearts and noted an increase in fractional shortening from 41±4% to 53±5% just five days after cell transplantation. These findings demonstrate that dATP is an inotropic factor that spreads between cells via gap junctions. Our data suggest that transplantation of dATP-producing hPSC-CMs could significantly increase the effectiveness of cardiac cell therapy.
登录
查看更多内容
影响因子:
5.5
作者:
Moreno-Gonzalez, Alicia;Gillis, Todd E.;Regnier, Michael
通讯作者:
Regnier, Michael
影响因子:
3.7
作者:
Liu J;Sun N;Bruce MA;Wu JC;Butte MJ
通讯作者:
Butte MJ
影响因子:
20.1
作者:
Kehat, I;Gepstein, A;Gepstein, L
通讯作者:
Gepstein, L
影响因子:
6
作者:
Laflamme, MA;Gold, J;Murry, CE
通讯作者:
Murry, CE
影响因子:
4.8
作者:
Goldberg, GS;Moreno, AP;Lampe, PD
通讯作者:
Lampe, PD